Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Politics and border hassles have chased away foreign visitors, costing businesses billions. Some fear next year’s World Cup won’t be enough to bring tourists back. By Christine Chung The United States ...

Healthcare costs are surging again, and U.S. employers are on the front lines. They purchase coverage for more than half of all Americans and are confronting significant increases in premiums—double ...